Don’t give pharmacists power over biosimilars: Australian Rheumatology Association

The Australian Rheumatology Association has expressed concerns about risks to patient safety it says could follow from measures on biosimilars going through the Senate today as part of the wider Pharmaceutical Benefits Bill. “The proposed new powers will allow pharmacists to switch particular drugs at the pharmacy counter with the potential for patients to get